Health product recall

M-Pregabalin 25mg Capsules (2019-08-21)

Starting date:
August 21, 2019
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type III
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-70931

Last updated: 2019-09-06

Summary

  • Product: M-Pregabalin

Reason

The assay is out of specification in the affected lot.

Depth of distribution

Wholesalers

Affected products

M-Pregabalin

DIN, NPN, DIN-HIM

DIN 02467291

Dosage form

Capsule

Strength

Pregabalin 25mg

Lot or serial number

1805001965

Companies

Recalling Firm
Marcan Pharmaceuticals Inc.
2 Gurdwara Rd.- Suite #112
Ottawa
K2E 1A2
Ontario
CANADA
Marketing Authorization Holder
Mantra Pharma Inc.
9150 Leduc Boulevard, Suite 201
Brossard
J4Y OE3
Quebec
CANADA

Date modified: